Back to Results
First PageMeta Content
Organochlorides / Psychiatry / Amines / Pfizer / Sertraline / Antidepressant / Major depressive disorder / Suicidal ideation / Desvenlafaxine / Chemistry / Organic chemistry / Selective serotonin reuptake inhibitors


DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857
Add to Reading List

Open Document

File Size: 34,25 KB

Share Result on Facebook

City

New York / Rockville / /

Company

Pfizer / the New York Times / PharmD Consumer Promotion / Moghaddassi Pfizer Pharmaceuticals / /

Event

FDA Phase / Reorganization / /

/

IndustryTerm

treatment of major depressive disorder / /

MedicalCondition

insomnia / panic attacks / major depressive disorder / psychiatric and nonpsychiatric disorders / psychomotor restlessness / depression / mania / akathisia / /

MedicalTreatment

drug therapy / /

Organization

Division of Neuropharmacological Drug Products / Food and Drug Administration / DEPARTMENT OF HEALTH / Division of Drug Marketing / Advertising / and Communications / /

Person

Kay A. Chitale / /

Position

physician / Analyst Regulatory Review Officer / /

Product

Zoloft / psychotropic drug / Zoloft® (sertraline HCl) Tablets / /

ProvinceOrState

Maryland / New York / /

PublishedMedium

the New York Times / /

SocialTag